Medtronic (MDT) Reports In-Line Q3 EPS; Guides Q4 In-Line
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mail
Get Alerts MDT Hot Sheet
Price: $98.88 -0.41%
EPS Growth %: -2.2%
Financial Fact:
Net sales: 4.32B
Today's EPS Names:
FUSE, INM, TRI, More
EPS Growth %: -2.2%
Financial Fact:
Net sales: 4.32B
Today's EPS Names:
FUSE, INM, TRI, More
Join SI Premium – FREE
Medtronic (NYSE: MDT) reported Q3 EPS of $1.37, in-line with the analyst estimate of $1.37. Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.94 billion.
GUIDANCE:
Medtronic sees Q4 2022 EPS of $1.56-$1.58, versus the consensus of $1.58. The company expects fourth quarter organic revenue growth of approximately 5.5%, in line with current fourth quarter organic revenue growth Street consensus.
For earnings history and earnings-related data on Medtronic (MDT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ultragenyx Pharma (RARE) Misses Q3 EPS by 6c; Offers Guidance
- JELD-WEN Holding, Inc. (JELD) Tops Q3 EPS by 1c, Misses on Revenue; Offers FY26 Revenue Guidance
- LTC Properties (LTC) Tops Q3 EPS by 22c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
